Location: Boston, MA
CIK: 0001595855 · Show all filings
Period: Q4 2022 (← Previous) (Next →)
Filing Date: Feb 10, 2023
Total Value: $288M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| HROW | HARROW HEALTH INC | 3,775,000 | $55.72M | 19.4% | $6.06 | +97.2% | COM | 415858109 |
| TELA | TELA BIO INC | 2,072,813 | $23.84M | 8.3% | $9.44 | -5.1% | COM | 872381108 |
| RYTM | RHYTHM PHARMACEUTICALS INC | 735,000 | $21.4M | 7.4% | $12.73 | +101.8% | COM | 76243J105 |
| OCUL | OCULAR THERAPEUTIX INC | 6,075,000 | $17.07M | 5.9% | $5.00 | -33.8% | COM | 67576A100 |
| CRNX | CRINETICS PHARMACEUTICALS INC | 732,000 | $13.4M | 4.7% | $20.83 | -15.4% | COM | 22663K107 |
| CYTK | CYTOKINETICS INC | 250,000 | $11.46M | 4.0% | $18.45 | +132.9% | COM NEW | 23282W605 |
| KROS | KEROS THERAPEUTICS INC | 238,000 | $11.43M | 4.0% | $49.36 | -5.4% | COM | 492327101 |
| PCVX | VAXCYTE INC | 177,000 | $8.487M | 3.0% | $38.73 | +1.3% | COM | 92243G108 |
| BHVN | BIOHAVEN LTD | 540,000 | $7.495M | 2.6% | $14.12 | 0.0% | COM | G1110E107 |
| FDMT | 4D MOLECULAR THERAPEUTICS INC | 330,000 | $7.329M | 2.5% | $20.97 | -26.3% | COM | 35104E100 |
| TARA | PROTARA THERAPEUTICS INC | 2,692,594 | $7.216M | 2.5% | $29.10 | -89.2% | COM STK | 74365U107 |
| — | TRACON PHARMACEUTICALS INC | 4,590,000 | $6.839M | 2.4% | $4.51 | — | COM NEW | 89237H209 |
| LRMR | LARIMAR THERAPEUTICS INC | 1,560,000 | $6.443M | 2.2% | $7.31 | -53.3% | COM | 517125100 |
| KALV | KALVISTA PHARMACEUTICALS INC | 923,200 | $6.241M | 2.2% | $5.36 | 0.0% | COM | 483497103 |
| ETON | ETON PHARMACEUTICALS INC | 2,170,000 | $6.119M | 2.1% | $6.13 | -56.1% | COM | 29772L108 |
| EWTX | EDGEWISE THERAPEUTICS INC | 611,400 | $5.466M | 1.9% | $10.83 | -13.4% | COM | 28036F105 |
| PRQR | PROQR THERAPEUTICS NV | 1,460,000 | $5.402M | 1.9% | $3.64 | -64.1% | SHS EURO | N71542109 |
| PHAT | PHATHOM PHARMACEUTICALS INC | 417,500 | $4.684M | 1.6% | $10.31 | 0.0% | COM | 71722W107 |
| XOMA | XOMA CORP DEL | 243,000 | $4.471M | 1.6% | $10.28 | +76.8% | COM NEW | 98419J206 |
| CDXS | CODEXIS INC | 957,500 | $4.462M | 1.6% | $3.62 | +51.2% | COM | 192005106 |
| URGN | UROGEN PHARMA LTD | 488,656 | $4.334M | 1.5% | $7.81 | +21.3% | COM | M96088105 |
| — | KARYOPHARM THERAPEUTICS INC | 1,206,841 | $4.282M | 1.5% | $3.55 | — | COM | 48576U106 |
| — | ASTRIA THERAPEUTICS INC | 261,703 | $3.897M | 1.4% | $11.91 | — | COM | 04635X102 |
| LQDA | LIQUIDIA CORPORATION | 560,000 | $3.567M | 1.2% | $5.49 | -2.1% | COM NEW | 53635D202 |
| ZNTL | ZENTALIS PHARMACEUTICALS INC | 167,500 | $3.373M | 1.2% | $21.51 | 0.0% | COM | 98943L107 |
| — | MARINUS PHARMACEUTICALS INC | 826,200 | $3.288M | 1.1% | $3.98 | — | COM NEW | 56854Q200 |
| EDAP | EDAP TMS S A | 306,713 | $3.27M | 1.1% | $10.10 | — | SPONSORED ADR | 268311107 |
| WHWK | AADI BIOSCIENCE INC | 252,046 | $3.234M | 1.1% | $13.06 | 0.0% | COM | 00032Q104 |
| — | MORPHOSYS AG | 896,600 | $3.21M | 1.1% | $3.78 | — | SPONSORED ADS | 617760202 |
| — | MERSANA THERAPEUTICS INC | 460,000 | $2.696M | 0.9% | $4.19 | — | COM | 59045L106 |
| — | THESEUS PHARMACEUTICALS INC | 535,000 | $2.664M | 0.9% | $5.30 | — | COM | 88369M101 |
| FENC | FENNEC PHARMACEUTICALS INC | 272,200 | $2.613M | 0.9% | $8.85 | 0.0% | COM | 31447P100 |
| IDYA | IDEAYA BIOSCIENCES INC | 138,800 | $2.522M | 0.9% | $16.78 | +0.2% | COM | 45166A102 |
| STXS | STEREOTAXIS INC | 1,185,000 | $2.453M | 0.9% | $2.93 | -33.4% | COM NEW | 85916J409 |
| BCAB | BIOATLA INC | 261,800 | $2.16M | 0.8% | $8.30 | 0.0% | COM | 09077B104 |
| — | FORTRESS BIOTECH INC | 2,050,000 | $1.343M | 0.5% | $2.69 | — | COM | 34960Q109 |
| — | ALLAKOS INC | 153,500 | $1.292M | 0.4% | $6.12 | — | COM | 01671P100 |
| TBPH | THERAVANCE BIOPHARMA INC | 87,600 | $983K | 0.3% | $10.51 | 0.0% | COM | G8807B106 |
| TRVI | TREVI THERAPEUTICS INC | 485,000 | $936K | 0.3% | $1.97 | 0.0% | COM | 89532M101 |
| MODD | MODULAR MEDICAL INC | 245,000 | $490K | 0.2% | $3.92 | -23.2% | COM NEW | 60785L207 |